ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹352 Cr | ₹392 Cr | ₹3,822 Cr | ₹406 Cr | ₹355 Cr |
What is the latest Consolidated Net Profit of ERIS LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹352 Cr |
| Mar2025 | ₹392 Cr |
| Mar2024 | ₹3,822 Cr |
| Mar2023 | ₹406 Cr |
| Mar2022 | ₹355 Cr |
How is Consolidated Net Profit of ERIS LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹352 Cr | -10.26 | |
| Mar2025 | ₹392 Cr | -89.74 | |
| Mar2024 | ₹3,822 Cr | 841.01 | |
| Mar2023 | ₹406 Cr | 14.35 | |
| Mar2022 | ₹355 Cr | - | |
Compare Consolidated Net Profit of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹15,827.8 Cr | -1.5% | -12.6% | -27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1.5% |
-12.6% |
-27.8% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses